CICERI, FABIO
 Distribuzione geografica
Continente #
AS - Asia 18.789
NA - Nord America 11.001
EU - Europa 8.647
SA - Sud America 5.609
AF - Africa 377
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 44.471
Nazione #
US - Stati Uniti d'America 10.433
SG - Singapore 8.294
CN - Cina 4.804
BR - Brasile 4.667
HK - Hong Kong 2.629
SE - Svezia 2.284
IT - Italia 2.273
VN - Vietnam 1.504
RU - Federazione Russa 978
DE - Germania 780
GB - Regno Unito 430
AR - Argentina 385
IN - India 332
FI - Finlandia 318
RO - Romania 276
CA - Canada 261
NL - Olanda 256
AT - Austria 248
JP - Giappone 209
MX - Messico 202
EC - Ecuador 174
BD - Bangladesh 167
PL - Polonia 161
ID - Indonesia 150
ZA - Sudafrica 150
FR - Francia 146
IE - Irlanda 134
TR - Turchia 126
ES - Italia 109
IQ - Iraq 107
PY - Paraguay 93
CO - Colombia 90
PK - Pakistan 69
CL - Cile 61
LT - Lituania 57
MA - Marocco 52
VE - Venezuela 52
UA - Ucraina 51
UZ - Uzbekistan 48
EG - Egitto 42
UY - Uruguay 37
PE - Perù 36
AU - Australia 35
SA - Arabia Saudita 35
AE - Emirati Arabi Uniti 34
DZ - Algeria 34
IR - Iran 34
IL - Israele 32
TN - Tunisia 29
KE - Kenya 23
KR - Corea 22
AZ - Azerbaigian 21
BE - Belgio 20
JO - Giordania 19
KZ - Kazakistan 19
CH - Svizzera 18
DO - Repubblica Dominicana 18
NP - Nepal 17
ET - Etiopia 14
JM - Giamaica 14
LB - Libano 14
AL - Albania 13
HN - Honduras 13
PH - Filippine 12
BY - Bielorussia 11
PA - Panama 11
DK - Danimarca 10
TH - Thailandia 10
TT - Trinidad e Tobago 10
BH - Bahrain 9
BO - Bolivia 9
CZ - Repubblica Ceca 9
KW - Kuwait 9
PT - Portogallo 9
SV - El Salvador 9
BG - Bulgaria 8
CR - Costa Rica 8
GR - Grecia 8
SY - Repubblica araba siriana 8
TW - Taiwan 8
BA - Bosnia-Erzegovina 7
BW - Botswana 7
NZ - Nuova Zelanda 7
OM - Oman 7
PS - Palestinian Territory 7
AO - Angola 6
GT - Guatemala 6
HU - Ungheria 6
MY - Malesia 6
AM - Armenia 5
CI - Costa d'Avorio 5
GE - Georgia 5
NG - Nigeria 5
NI - Nicaragua 5
NO - Norvegia 5
RS - Serbia 5
BB - Barbados 4
KG - Kirghizistan 4
LV - Lettonia 4
MK - Macedonia 4
Totale 44.421
Città #
Singapore 3.558
Hong Kong 2.609
Dallas 1.972
Ashburn 1.399
Shanghai 1.284
Hefei 1.094
Lawrence 812
Princeton 811
Milan 658
Beijing 580
New York 573
Ho Chi Minh City 565
São Paulo 439
Moscow 355
Los Angeles 340
Hanoi 308
Nuremberg 240
Boardman 226
Rome 179
Munich 176
Helsinki 161
Rio de Janeiro 150
Tokyo 144
Warsaw 135
Dublin 124
Brooklyn 121
Vienna 118
Denver 112
Belo Horizonte 106
Montreal 103
Santa Clara 103
Washington 98
Cesano Boscone 96
Chennai 93
Orem 93
Johannesburg 92
Stockholm 92
Poplar 89
Guangzhou 86
London 83
Lappeenranta 80
Brasília 78
Curitiba 77
Atlanta 73
Seattle 73
Brescia 72
Turku 71
Mexico City 70
Ankara 67
Campinas 67
Guayaquil 65
Phoenix 64
Toronto 64
Boston 63
Chicago 63
Castelseprio 61
Haiphong 61
Pune 61
Amsterdam 60
Manchester 59
The Dalles 59
Quito 58
Porto Alegre 56
Salvador 53
Houston 52
Da Nang 51
Frankfurt am Main 51
Hangzhou 45
Biên Hòa 44
Tashkent 44
Bologna 41
Guarulhos 40
Santo André 40
Council Bluffs 39
Goiânia 39
Shenzhen 38
Tianjin 37
Buenos Aires 36
Baghdad 35
Columbus 35
Hải Dương 35
Dhaka 34
Jakarta 34
Querétaro 33
San Francisco 33
Thái Bình 33
Bergamo 32
Mumbai 32
Ribeirão Preto 32
Manaus 31
Turin 31
Montevideo 30
Chandler 29
San Jose 29
Shijiazhuang 29
Changsha 28
Monza 28
Sorocaba 28
São Gonçalo 27
Falkenstein 26
Totale 23.233
Nome #
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study 344
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy 328
Use of HSV-TK transduced donor lymphocytes in the context of allogeneic bone marrow transplantation: A paradigm of current applications and limitations in gene therapy 192
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 192
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 167
Loss of mismatched HLA in leukemia after stem-cell transplantation 135
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 133
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 132
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 124
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations 123
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 120
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 118
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 115
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia 115
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 114
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 114
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 110
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 109
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 109
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 109
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 109
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 108
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 106
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 106
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 106
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 103
Validation of the “fitness criteria” for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL) 103
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 103
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 102
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 100
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 98
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 97
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 95
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 95
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 95
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 95
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells 94
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 93
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study 93
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 92
A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation 92
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 91
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 91
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 91
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 90
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 89
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 88
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 88
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 87
A T cell epitope encoded by a subset HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation 87
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 86
Biobanking for COVID-19 research 86
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 86
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 85
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 84
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation 83
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 83
Bone marrow as source of hematopoietic stem cells for human gene therapy of beta thalassemia 83
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 83
CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature 82
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT 82
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 82
Erratum: IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism (Molecular Therapy (2017) 25(10) (2254–2269), (S1525001617303143), (10.1016/j.ymthe.2017.06.029)) 82
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 81
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 81
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 81
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 81
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain 81
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 80
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 80
Gene therapy for immunodeficiency due to adenosine deaminase deficiency 79
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 79
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub 79
Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients 79
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 79
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 78
A dual role for genetically modified lymphocytes in cancer immunotherapy 78
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study 78
Long-term lineage commitment in haematopoietic stem cell gene therapy 77
QTc interval prolongation, inflammation, and mortality in patients with COVID-19 77
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 77
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies 77
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 76
A PHASE II STUDY ON INTENSIVE ALL TYPE CHEMOTHERAPY WITH MINIMAL RESIDUAL DISEASE (MRD) ORIENTED POSTREMISSION STRATEGY IN ADULT PATIENTS WITH LYMPHOBLASTIC LYMPHOMA (PROTOCOL NILG-ALL NO. 09/00) 76
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 76
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation 75
Leukemic blasts secondary to myelodysplastic syndromes are molecularly programmed to differentiate into functionally mature dendritic cells 75
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 75
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 73
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 73
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome 73
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 72
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 72
A Phase III Study of Enoxaparin Versus Low-Dose Warfarin Versus Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated up-Front with Thalidomide-Containing Regimens 72
After Action Reviews of COVID-19 response: Case study of a large tertiary care hospital in Italy 72
One-year mental health outcomes in a cohort of COVID-19 survivors 72
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 72
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 71
Autologous haematopoietic stem cell transplantation with thiotepa-cyclophosphamide conditioning in aggressive multiple sclerosis: clinical experience in eight patients 71
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease 71
Totale 9.796
Categoria #
all - tutte 369.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 369.156


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 51 20 8 25 1 13 4
2021/2022751 11 2 8 240 55 36 65 102 57 90 27 58
2022/20234.925 1.762 862 248 92 190 567 209 334 392 76 113 80
2023/20243.456 201 226 396 356 327 626 192 273 29 137 179 514
2024/202515.321 1.666 466 330 469 478 1.261 2.153 1.449 2.453 2.072 1.175 1.349
2025/202620.899 3.269 3.468 3.223 6.709 3.355 875 0 0 0 0 0 0
Totale 45.881